Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis

The 5-hydroxytryptamine receptor 6 (5-HT6) has gained attention as a target for developing therapeutics for Alzheimer’s disease, schizophrenia, cognitive dysfunctions, anxiety, and depression, to list a few. In the present analysis, a larger and diverse dataset of 1278 molecules covering a broad che...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Syed Nasir Abbas Bukhari, Mervat Abdelaziz Elsherif, Kashaf Junaid, Hasan Ejaz, Pravej Alam, Abdul Samad, Rahul D. Jawarkar, Vijay H. Masand
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-07-01
Schriftenreihe:	Pharmaceuticals
Schlagworte:	5-hydroxytryptamine receptor 6 neurodegeneration QSAR molecular docking pharmacophoric features
Online-Zugang:	https://www.mdpi.com/1424-8247/15/7/834
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!